These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1910486

  • 1. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure.
    Kaufmann H, Oribe E, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):143-8. PubMed ID: 1910486
    [Abstract] [Full Text] [Related]

  • 2. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD.
    Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
    [Abstract] [Full Text] [Related]

  • 3. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.
    Freeman R, Landsberg L, Young J.
    Neurology; 1999 Dec 10; 53(9):2151-7. PubMed ID: 10599797
    [Abstract] [Full Text] [Related]

  • 4. Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment.
    Ushiyama M, Ikeda S, Suzuki T, Yazawa M, Yanagisawa N, Tsujino S.
    J Neurol Neurosurg Psychiatry; 1996 Jul 10; 61(1):99-102. PubMed ID: 8676171
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS, Holmes C, Kaufmann H, Freeman R.
    Clin Auton Res; 2004 Dec 10; 14(6):363-8. PubMed ID: 15666063
    [Abstract] [Full Text] [Related]

  • 6. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R.
    Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750
    [Abstract] [Full Text] [Related]

  • 7. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
    Kaufmann H.
    Clin Auton Res; 2008 Mar 12; 18 Suppl 1():19-24. PubMed ID: 18368303
    [Abstract] [Full Text] [Related]

  • 8. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans.
    Iwase S, Mano T, Kunimoto M, Saito M.
    J Auton Nerv Syst; 1992 Jun 15; 39(2):159-67. PubMed ID: 1430796
    [Abstract] [Full Text] [Related]

  • 9. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
    Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I.
    Neurology; 1988 Jul 15; 38(7):1091-4. PubMed ID: 3133573
    [Abstract] [Full Text] [Related]

  • 10. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
    Hoeldtke RD, Cilmi KM, Mattis-Graves K.
    Clin Pharmacol Ther; 1984 Sep 15; 36(3):302-6. PubMed ID: 6432398
    [Abstract] [Full Text] [Related]

  • 11. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G, Holmes C, Sullivan P, Goldstein DS.
    Clin Auton Res; 2019 Feb 15; 29(1):113-117. PubMed ID: 30229336
    [Abstract] [Full Text] [Related]

  • 12. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
    Mathias CJ.
    Clin Auton Res; 2008 Mar 15; 18 Suppl 1():25-9. PubMed ID: 18368304
    [Abstract] [Full Text] [Related]

  • 13. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Matsumoto M, Yoneda S.
    Eur Neurol; 1985 Mar 15; 24(5):330-4. PubMed ID: 3932074
    [Abstract] [Full Text] [Related]

  • 14. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine.
    Freeman R, Young J, Landsberg L, Lipsitz L.
    Neurology; 1996 Dec 15; 47(6):1414-20. PubMed ID: 8960720
    [Abstract] [Full Text] [Related]

  • 15. The discovery of the pressor effect of DOPS and its blunting by decarboxylase inhibitors.
    Kaufmann H.
    J Neural Transm Suppl; 2006 Dec 15; (70):477-84. PubMed ID: 17017570
    [Abstract] [Full Text] [Related]

  • 16. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
    Suzuki T, Higa S, Tsuge I, Sakoda S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A.
    Eur J Clin Pharmacol; 1980 Jun 15; 17(6):429-35. PubMed ID: 6772451
    [Abstract] [Full Text] [Related]

  • 17. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
    Man in 't Veld AJ, Boomsma F, van den Meiracker AH, Julien C, Lenders J, Schalekamp MA.
    J Hypertens Suppl; 1988 Dec 15; 6(4):S547-9. PubMed ID: 3149290
    [Abstract] [Full Text] [Related]

  • 18. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S, Oyabe A, Tanno M, Suzuki-Kusaba M.
    Arzneimittelforschung; 1989 Sep 15; 39(9):1123-9. PubMed ID: 2511849
    [Abstract] [Full Text] [Related]

  • 19. Droxidopa in neurogenic orthostatic hypotension.
    Kaufmann H, Norcliffe-Kaufmann L, Palma JA.
    Expert Rev Cardiovasc Ther; 2015 Sep 15; 13(8):875-91. PubMed ID: 26092297
    [Abstract] [Full Text] [Related]

  • 20. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
    Iida N, Koshikawa S, Akizawa T, Tsubakihara Y, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M.
    Am J Nephrol; 2002 Sep 15; 22(4):338-46. PubMed ID: 12169865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.